Business, Education and Schools, Free News Articles, Ophthalmology and Vision

Paragon Gives Announces Call for 2020 Koch Kellan Scholarship Applicants

PORTLAND, Ore. -- Paragon Gives, a Paragon BioTeck, Inc. initiative, is excited to announce a call for applications for the 2020 Koch Kellan Scholarship worth $10,000. This annual scholarship is awarded to one (1) outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.

"Through the Koch Kellan Scholarship program, Paragon Gives cultivates a next-generation leader in ophthalmology," stated Patrick Witham, President & CEO of Paragon BioTeck. "By recognizing the talents and commitments of an ophthalmic innovator each year, we help build a stronger profession and further Paragon's mission to continually elevate the standard of eye care."

Applications will be reviewed by scholarship namesakes and industry giants: Paul S. Koch, MD, and Robert E. Kellan, MD, as well as additional members of the Scholarship Review Committee. Once selected, the Koch Kellan Scholar will be invited to attend the 2020 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Boston, Massachusetts, to be held on May 15-19. The Scholar will be formally presented with the award during the ASCRS conference and will interact with Paragon representatives and ophthalmologists to learn more about the industry.

"Those for whom ophthalmology is truly a calling; those for whom it would be impossible to pursue any other specialty; and those who are able to convey this personal connection in a captivating matter-these are the students whom the Koch Kellan Scholarship is intended to support," said Patrick Witham, founder of the Koch Kellan scholarship. "It is our honor and pleasure to mark the professional contributions of Doctors Koch and Kellan by continuing their long legacy of mentorship in our field."

The 2019 Koch Kellan Scholarship recipient, Mohima Sanyal, was a third-year student at the University of Pennsylvania Perelman School of Medicine. She attends medical school with the personal ambition to apply her interdisciplinary perspectives towards providing excellent, accessible medical care to patients. She believes that access to "excellent healthcare is fundamental to a just society and that it is critical that we engage with community-specific visual health needs and contribute to innovative, culturally-informed solutions." Her projects involve creating a more inclusive, theoretically-grounded approach to visual care research, applying the power of narrative medicine to mitigate implicit bias in physician practice, and eliminating language and insurance barriers for care.

The Koch Kellan Scholarship application and guidelines are available at Koch Kellan.com. Application submissions are open from November 18, 2019, through February 16, 2020, and all supporting materials must be postmarked by February 16, 2020. The Koch Kellan Scholarship reinforces the fundamental mission of Paragon BioTeck, "to drive innovations to address unmet and underserved medical needs and improve the quality of lives around the world."

About Paragon Gives and the Koch Kellan Scholarship

Paragon Gives, a Paragon BioTeck, Inc. initiative, supports several charities and organizations, including those within the biotechnology and health care arena. The initiative also works with individuals and organizations that have made a positive impact on our customers, vendors, investors, and industry as a whole.

The Koch Kellan Scholarship affirms the commitment of Paragon BioTeck to elevating the standard of eye care through addressing unmet and underserved medical needs and improving the quality of lives around the world.

Learn more about the scholarship and its recipients at: https://paragonBioTeck.com/gives/KochKellan/.

About Paragon BioTeck, Inc.

Paragon BioTeck, Inc., is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices, and therapies. Paragon BioTeck's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes. Learn more about Paragon BioTeck at https://paragonBioTeck.com/.

Media Contact:
Caity Fager
Paragon BioTeck, Inc.
(888) 424-1192
marketing@paragonbioteck.com

*PHOTO link for media: https://www.Send2Press.com/300dpi/19-1119s2p-senyal-koch-kellan-300dpi.jpg
*Photo caption: Mohima Sanyal, 2019 recipient of the Koch Kellan scholarship, center, and (from the left) Patrick Witham, CEO and president of Paragon BioTeck, Doctor Robert E. Kellan, a board-certified ophthalmologist specializing in cataract and lens implant surgery, and Doctor Paul S. Koch, co-founder and medical director of Koch Eye Associates, officially presents Mohima with her scholarship. This scholarship is but a piece of the recognition Paragon Gives, a Paragon BioTeck, Inc. initiative, does to support the future of ophthalmology.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Awards and Honors, Business, Education and Schools, Free News Articles, Ophthalmology and Vision

Mohima Sanyal Named 2019 Koch Kellan Scholar

PORTLAND, Ore. -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Mohima Sanyal has been named its 2019 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and through a clinical, teaching, or research career in ophthalmology.

"Mohima's credentials reflect a commitment to science and to public health. She plans to study ophthalmology and has already shown an interest and an aptitude for that specialty," said Paul Koch MD, one of the doctors whose namesake is attached to the scholarship. "She has the background to apply what she learns in the vast world of underserved populations both here and abroad. If she continues along this path, she will be a valuable teacher and influencer in the world of medicine."

Ms. Sanyal is a third-year student at the University of Pennsylvania Perelman School of Medicine. She attends medical school with the personal ambition to apply her interdisciplinary perspectives towards providing excellent, accessible medical care to patients. She believes that access to "excellent healthcare is fundamental to a just society, and that it is critical that we engage with community-specific visual health needs and contribute to innovative, culturally-informed solutions." Her projects involve creating a more inclusive, theoretically-grounded approach to visual care research, applying the power of narrative medicine to mitigate implicit bias in physician practice, and eliminating language and insurance barriers for care.

"It means so much to be recognized by luminaries in this field - Drs. Koch and Kellan, as well as Paragon BioTeck - for my dedication to the field of ophthalmology and to providing excellent, equitable medical care to all," said Sanyal.

Ms. Sanyal has applied her interdisciplinary perspectives through her work with the Primary Open-Angle African-American Glaucoma Genetics Study (a National Institutes of Health study), by giving back to her community with the Give Kids Sight Day as a volunteer coordinator, and through various avenues related to ophthalmology.

"I was extremely impressed with the extraordinary measures she has taken in her pursuit to achieve a global perspective of how best to address visual-related health needs. Her MD-Master of Public Health degree combined with her MSc in Cognitive and Evolutionary Anthropology will give her the necessary credentials and those along with her enviable selfless attitude will guarantee her a leadership role in her field," said Robert Kellan MD, the scholarship's other namesake.

Paragon Gives will formally present the Koch Kellan Scholarship to Ms. Sanyal at a breakfast attended by Drs. Koch and Kellan, and Paragon CEO, Patrick Witham, during the annual meeting of the American Society of Cataract and Refractive Surgery, held May 5, 2019 in San Diego, California.

Patrick Witham discusses the importance of the scholarship in regard to ophthalmology, "Since its inception, this award has been extended to some of the best and brightest, up and coming stars in this area of medicine. The award's namesake is perfectly apt, given the unparalleled caliber of candidates and recipients that have shown interest in pursuing a career in an area of medicine where both Dr. Koch and Dr. Kellan have made such tremendously important contributions."

About Paragon Gives and the Koch Kellan Scholarship:

Paragon Gives, a Paragon BioTeck, Inc., initiative, supports a number of charities and organizations, including those within the biotechnology and health care arena. The initiative also works with individuals and organizations that have made a positive impact on our customers, vendors, investors, and industry as a whole.

The Koch Kellan Scholarship affirms Paragon's commitment to elevating the standard of eye care and enhancing patient quality of life. Mohima Sanyal is the fifth recipient of the scholarship. Previous recipients include Alejandro Arboleda of the University of Miami Miller School of Medicine, and Xinxin Zhang of the University of North Carolina, Chapel Hill. The scholarship was first awarded to Captain Edward Woodward of the University of South Florida Morsani College of Medicine in 2015.

Learn more about the scholarship and its recipients at: https://paragonBioTeck.com/gives/KochKellan/.

About Paragon BioTeck, Inc.:

Paragon BioTeck, Inc., is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon BioTeck's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes. Learn more about Paragon BioTeck at https://paragonBioTeck.com/.

Media Contact:
Angela Morgan
angela.morgan@focuslaboratories.com

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Awards and Honors, Drugs and Pharmaceuticals, Education and Schools, Free News Articles, Ophthalmology and Vision

Alejandro Arboleda Named 2018 Koch Kellan Scholar

PORTLAND, Ore. -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and medical device company, announced today that Alejandro Arboleda has been named its 2018 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching or research career in ophthalmology.

Patrick Witham, President and CEO of Paragon BioTeck, discussed the importance of the scholarship in regard to ophthalmology, "Since its inception, this award has been extended to some of the best and brightest up and coming stars in this area of medicine. The award's namesake is perfectly apt, given the unparalleled caliber of candidates and recipients that have shown interest in pursuing a career in an area of medicine where both Dr. Koch and Dr. Kellan have made such tremendously important contributions."

Witham added, "While the contributions they have made to restoring sight in and of itself is remarkable, it is their vision that they so generously share that will leave their indelible mark on countless lives well beyond our time."

Both Robert Kellan, MD and Paul Koch, MD, spoke of Mr. Arboleda's determination to pursue a career in ophthalmology. "While many students imagine how things ought to be and wonder why not, Alejandro stepped out where few others do. He took actions to accomplish changes in the world around him. I have no doubt he has the temperament and the drive to accomplish many wonderful things and change our world as we know it," Koch stated.

Mr. Arboleda is a third-year student at the University of Miami Miller School of Medicine. His initial studies in biomedical engineering drove his interest in ophthalmology. "I was not satisfied by simply creating novel devices, I wanted to be the physician with the experience to face problems and invent better solutions to treat patients," he said. After collaborating with researchers in France during his tenure as a Fulbright Fellow, he began a photodynamic therapy (PDT) project.

Kellan noted Mr. Arboleda's passion for caring for those in need, "Alejandro clearly demonstrates his compassion to make the world a better place by his eager participation in ophthalmic mission trips to South America and his tireless efforts to bring visual rehabilitation to the needy."

Mr. Arboledo expressed how these experiences reaffirmed his dedication to medicine, "I have followed each patient's journey and am humbled by their reactions to their recovery."

Upon receipt of the award, Mr. Arboleda discussed how the scholarship mirrors both his commitment to driving innovation and serving the population, "I feel very honored to receive the Koch Kellan Scholarship. I look forward to dedicating my career to the field of ophthalmology where there is so much space for advancement and serving diverse patient populations. I will continue to work hard so that my contributions to the field of ophthalmology honor the spirit of this award."

Paragon Gives will formally present the Koch Kellan Scholarship to Mr. Arboleda at a dinner attended by scholarship namesakes, Drs. Koch and Kellan, and Paragon CEO, Patrick Witham, during the annual meeting of the American Society of Cataract and Refractive Surgery, held April 14-17, 2018 in Washington D.C.

About Paragon Gives and the Koch Kellan Scholarship:

Paragon Gives, a Paragon BioTeck, Inc., initiative, supports a number of charities and organizations, including those within the biotechnology and health care arena. The initiative also works with individuals and organizations that have made a positive impact on our customers, vendors, investors and industry as a whole.

The Koch Kellan Scholarship affirms Paragon's commitment to elevating the standard of eye care and enhancing patient quality of life. Alejandro Arboleda is the fourth recipient of the scholarship. Previous recipients include Xinxin Zhang of the University of North Carolina, Chapel Hill, and Hasenin Al-khersan of the University of Chicago Pritzker School of Medicine. The scholarship was first awarded to Captain Edward Woodward of the University of South Florida Morsani College of Medicine in 2015.

Learn more at: https://paragonbioteck.com/gives/kochkellan/.

About Paragon BioTeck, Inc.:

Paragon BioTeck, Inc., is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon BioTeck's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes.

Learn more at: https://paragonbioteck.com/.

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Drugs and Pharmaceuticals, Education and Schools, Free News Articles, Ophthalmology and Vision

Paragon BioTeck Calls Emerging Leaders to Apply for 2018 Ophthalmology Scholarship

PORTLAND, Ore. -- Paragon BioTeck, Inc., a privately-held pharmaceutical and medical device company, today announced the call for the next Koch Kellan Scholar. The annual Koch Kellan Scholarship honors one outstanding graduate medical student committed to elevating the standard of eye care through social responsibility and a clinical, teaching, or research career in ophthalmology. A Paragon Gives initiative, the scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs.

Download the 2018 Koch Kellan Scholarship application and guidelines at http://kochkellan.com/. Application materials will be accepted until January 16, 2018.

"The Koch Kellan Scholarship program celebrates the contributions of namesakes Drs. Koch and Kellan and fosters the future leaders in ophthalmology," said Patrick Witham, President & CEO of Paragon BioTeck. "Each year, we are astounded by the incredible pool of candidates and are honored that so many aim to cultivate an elevated standard of eye care. We are excited to welcome the next Koch Kellan Scholar to the Paragon family."

Applications will be reviewed by industry leaders Paul S. Koch, MD, and Robert E. Kellan, MD, along with additional members of the Scholarship Review Committee. The 2018 Scholar will formally be presented with the award at the 2018 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting held April 13-17 in Washington, D.C.

The 2017 Koch Kellan Scholar, Xinxin Zhang, is a third-year student attending the University of North Carolina, Chapel Hill. Her passion for ophthalmology was confirmed during a research project dedicated to bringing diagnostic innovations to some of China's poorest provinces, where high rates of preventable blindness occur primarily due to lack of screening. She spent 2016 researching dry eye disease and leading UNC's student-run ophthalmology clinic.

About Paragon Gives and the Koch Kellan Scholarship:

Paragon Gives is a Paragon BioTeck, Inc., initiative that supports charities and organizations within the biotechnology and health care arena. The initiative also works with individuals and organizations that have made a positive impact on our customers, vendors, investors and industry as a whole.

The Koch Kellan Scholarship affirms the commitment of Paragon BioTeck to elevate the standard of eye care through addressing unmet and underserved medical needs and improving the quality of lives around the world. It was first awarded to Captain Edward Woodward of the University of South Florida Morsani College of Medicine, whose compelling personal connection to the field made him the ideal inaugural recipient. Learn more about our past scholars: http://kochkellan.com/scholars/.

About Paragon BioTeck, Inc.:

Paragon BioTeck, Inc. is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon BioTeck's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes. Information: https://paragonbioteck.com/.

LOGOS for Media:
* Send2Press.com/300dpi/17-1002s2p-paragongives-300dpi.jpg
* Send2Press.com/300dpi/17-1002s2p-paragonbio-300dpi.jpg

MEDIA CONTACT:
Stefanie Henning
Paragon BioTeck, Inc.
888-424-1192
marketing@paragonbioteck.com

Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Education and Schools, Free News Articles, Ophthalmology and Vision

Xinxin Zhang Named 2017 Koch Kellan Scholar

PORTLAND, Ore. -- Paragon BioTeck, Inc., an ophthalmic pharmaceutical and device company, announced today that Xinxin Zhang has been named its 2017 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck initiative, awards the Koch Kellan Scholarship to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology.

"We are wholeheartedly committed to furthering education and shining a light on the next generation of ophthalmic innovators, such as Xinxin Zhang," remarked Patrick Witham, President & CEO.

Both Robert Kellan, MD, and Paul Koch, MD, are impressed by Ms. Zhang's early dedication to ophthalmology and her strong desire to serve underprivileged populations. "Xinxin exemplifies the values of Paragon BioTeck and this scholarship through her volunteer work at free clinics, similar to those that supported her and her family when they first moved to the U.S. from China, as well as the research project she undertook in her country of origin. She will be a great future leader of ophthalmology," Koch stated.

Xinxin Zhang is a third-year student at the University of North Carolina, Chapel Hill. Her experiences with poverty as a child exposed her to many treatable eye conditions at an early age and sparked her desire to serve. Ms. Zhang's passion for ophthalmology was cemented during a research project focused on bringing technological diagnostic advances to some of China's poorest provinces, where high rates of preventable blindness occur primarily due to lack of screening opportunities. After spending last year researching dry eye disease and leading UNC's student-run ophthalmology clinic, Ms. Zhang is committed to bringing ophthalmological innovation to the rural areas of the state she has come to call home.

Upon receipt of the award, Ms. Zhang expressed her appreciation not only for the financial assistance that the scholarship provides, but also for the spotlight that it places on ophthalmology. "Ophthalmology is not always at the forefront of people's minds when they think of mainstream medicine. As a student who is very passionate about ophthalmology and its impact, it is extremely encouraging and validating to find a scholarship that honors my future profession."

Paragon Gives will formally present the Koch Kellan Scholarship to Ms. Zhang at an event attended by scholarship namesakes, Drs. Koch and Kellan, as well as other distinguished industry leaders, at the annual meeting of the American Society of Cataract and Refractive Surgery, held May 6-8, 2017 in Los Angeles.

About Paragon Gives and the Koch Kellan Scholarship:

Paragon Gives, a Paragon BioTeck, Inc., initiative, supports a number of charities and organizations, including those within the biotechnology and health care arena. The initiative also works with individuals and organizations that have made a positive impact on our customers, vendors, investors and industry as a whole.

The Koch Kellan Scholarship affirms Paragon's commitment to elevating the standard of eye care and enhancing patient quality of life. Xinxin Zhang is the third recipient of the scholarship. The 2016 recipient was Hasenin Al-khersan of University of Chicago Pritzker School of Medicine, and the scholarship was first awarded to Captain Edward Woodward of the University of South Florida Morsani College of Medicine in 2015.

About Paragon BioTeck:
Paragon BioTeck, Inc., is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon BioTeck's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes.

More information: https://paragonbioteck.com/.

Join the conversation:
Facebook: https://www.facebook.com/ParagonBioTeck/
Twitter: @ParagonBioTeck

MEDIA CONTACT:
Shannon Severino
412-608-2393
shannon@pascalecommunications.com

IMAGES FOR MEDIA:
* PHOTO: Send2Press.com/mediaboom/17-0412s2p-Xinxin-Zhang-300dpi.jpg
* Photo Caption: Xinxin Zhang, 2017 Koch Kellan Scholar.

* LOGO: Send2Press.com/mediaboom/17-0412s2p-paragives-300dpi.jpg

This news story was published by the Neotrope® News Network - all rights reserved.

Drugs and Pharmaceuticals, Free News Articles, Ophthalmology and Vision

Paragon BioTeck, Inc. Announces Call for 2017 Koch Kellan Scholarship Applicants

PORTLAND, Ore. -- Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today a call for applications for the 2017 Koch Kellan Scholarship, awarded annually to an outstanding graduate medical student committed to pursuing a clinical, teaching or research career in ophthalmology. A Paragon Gives initiative, the Koch Kellan Scholarship reinforces the fundamental mission of Paragon BioTeck to drive innovations to address unmet and underserved medical needs and improve the quality of lives around the world.

The Koch Kellan Scholarship application and guidelines will be available at KochKellan.com (http://kochkellan.com/) from September 1, 2016, through December 1, 2016. The application and all supporting materials must be postmarked by December 1, 2016.

Applications will be reviewed by scholarship namesakes and industry giants: Paul S. Koch, MD, and Robert E. Kellan, MD, and additional members of the Scholarship Review Committee. Once selected, the 2017 Koch Kellan Scholar will be invited to attend the 2017 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Los Angeles, to be held May 5-9. At the conference, the Scholar will be formally presented with the award and given the opportunity to learn more about the ophthalmic industry.

"It is our honor and pleasure to mark the professional contributions of Doctors Koch and Kellan by continuing their long legacy of mentorship in our field," stated Patrick Witham, President & CEO of Paragon BioTeck. "Through the Koch Kellan Scholarship program, Paragon Gives cultivates a next-generation leader in ophthalmology. By recognizing the talents and commitments of a new ophthalmic innovator each year, we help build a stronger profession and further Paragon's mission to continually elevate the standard of eye care."

The 2016 Koch Kellan Scholarship was awarded to Hasenin Al-khersan, a third-year student at the University of Chicago Pritzker School of Medicine. As an adolescent, Mr. Al-khersan accompanied his grandmother to her glaucoma appointments, serving as a translator; later, he deepened his ophthalmic interests through cataract and glaucoma research and volunteering as the leader of Sight Savers, an organization that provides free glaucoma and vision screenings for the South Side Chicago community.

About Paragon Gives and the Koch Kellan Scholarship:
Paragon Gives (https://paragonbioteck.com/gives/), a Paragon BioTeck, Inc., initiative, supports a number of charities and organizations, including those within the biotechnology and health care arena. The initiative also works with individuals and organizations that have made a positive impact on our customers, vendors, investors and industry as a whole.

The Koch Kellan Scholarship affirms the commitment of Paragon BioTeck to elevating the standard of eye care through addressing unmet and underserved medical needs and improving the quality of lives around the world. It was first awarded to Captain Edward Woodward of the University of South Florida Morsani College of Medicine, whose compelling personal connection to the field made him the ideal inaugural recipient.

About Paragon BioTeck, Inc.:
Paragon BioTeck, Inc. (https://paragonbioteck.com/) is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies. Paragon BioTeck's portfolio of products is designed to protect and preserve eyesight and deliver comfort to the eyes.

LOGOS:
* Send2Press.com/mediaboom/16-0901-paragongives-300dpi.jpg
* Send2Press.com/mediaboom/16-0329-paragonbio-300dpi.jpg

This news story was published by the Neotrope® News Network - all rights reserved.